Current treatments target the mitogen-activated protein kinase (MAPK) pathway, a key driver of melanoma growth. However, MAPK ...

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is ...

My research focuses on developing rational combinations to overcome drug resistance in melanoma, lung and colorectal cancers. In particular, I explore pharmacological targeting and characterization of ...

Mitogen-activated protein kinase (MAPK) and Wnt signaling pathways are critical for melanocyte ... ligustroside on α-MSH-induced B16F10 murine melanoma cells. The cytotoxicity of ligustroside ...